Washington, Sept. 23 -- Congressman Chris Deluzio issued the following press release:
CARNEGIE, PA - Today, Congressman Chris Deluzio (PA-17) announced that the U.S. Department of Health & Human Services has awarded a $306,756 grant to KaliVir Immunotherapeutics of O'Hara Township, PA for cancer treatment research. This federal funding is a Small Business Innovation Research Grant (SBIR) - Phase II from the National Cancer Institute. KaliVir Immunotherapeutics develops next-generation, viral-based therapies (oncolytic viruses) that both directly destroy tumor cells as well as attract and activate an anti-tumor immune response. "I'm proud to announce federal funding to support cutting-edge research for cancer treatment right here in Western...